ENOVIS CORP (ENOV) Fundamental Analysis & Valuation

NYSE:ENOV • US1940141062

Current stock price

22.99 USD
-0.4 (-1.71%)
At close:
22.99 USD
0 (0%)
After Hours:

This ENOV fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. ENOV Profitability Analysis

1.1 Basic Checks

  • In the past year ENOV was profitable.
  • In the past year ENOV had a positive cash flow from operations.
  • In the past 5 years ENOV reported 4 times negative net income.
  • Of the past 5 years ENOV 4 years had a positive operating cash flow.
ENOV Yearly Net Income VS EBIT VS OCF VS FCFENOV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -500M -1B

1.2 Ratios

  • With a Return On Assets value of -30.89%, ENOV perfoms like the industry average, outperforming 40.76% of the companies in the same industry.
  • ENOV has a Return On Equity (-79.51%) which is in line with its industry peers.
  • ENOV has a Return On Invested Capital of 0.46%. This is in the better half of the industry: ENOV outperforms 66.30% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for ENOV is significantly below the industry average of 9.18%.
  • The last Return On Invested Capital (0.46%) for ENOV is above the 3 year average (0.36%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -30.89%
ROE -79.51%
ROIC 0.46%
ROA(3y)-16.37%
ROA(5y)-9.72%
ROE(3y)-37.57%
ROE(5y)-22.31%
ROIC(3y)0.36%
ROIC(5y)N/A
ENOV Yearly ROA, ROE, ROICENOV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -20 -40 -60

1.3 Margins

  • The Operating Margin of ENOV (0.84%) is better than 66.30% of its industry peers.
  • ENOV's Operating Margin has declined in the last couple of years.
  • ENOV has a Gross Margin (58.16%) which is comparable to the rest of the industry.
  • ENOV's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 0.84%
PM (TTM) N/A
GM 58.16%
OM growth 3YN/A
OM growth 5Y-34.45%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.43%
GM growth 5Y6.64%
ENOV Yearly Profit, Operating, Gross MarginsENOV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40

3

2. ENOV Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ENOV is destroying value.
  • Compared to 1 year ago, ENOV has more shares outstanding
  • The number of shares outstanding for ENOV has been increased compared to 5 years ago.
  • ENOV has a worse debt/assets ratio than last year.
ENOV Yearly Shares OutstandingENOV Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
ENOV Yearly Total Debt VS Total AssetsENOV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.2 Solvency

  • ENOV has an Altman-Z score of 0.60. This is a bad value and indicates that ENOV is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of ENOV (0.60) is comparable to the rest of the industry.
  • ENOV has a debt to FCF ratio of 65.11. This is a negative value and a sign of low solvency as ENOV would need 65.11 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 65.11, ENOV is in the better half of the industry, outperforming 68.48% of the companies in the same industry.
  • ENOV has a Debt/Equity ratio of 0.85. This is a neutral value indicating ENOV is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.85, ENOV is doing worse than 72.28% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.85
Debt/FCF 65.11
Altman-Z 0.6
ROIC/WACC0.06
WACC8.14%
ENOV Yearly LT Debt VS Equity VS FCFENOV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B 4B

2.3 Liquidity

  • A Current Ratio of 2.02 indicates that ENOV has no problem at all paying its short term obligations.
  • The Current ratio of ENOV (2.02) is worse than 63.59% of its industry peers.
  • A Quick Ratio of 1.04 indicates that ENOV should not have too much problems paying its short term obligations.
  • ENOV's Quick ratio of 1.04 is on the low side compared to the rest of the industry. ENOV is outperformed by 76.63% of its industry peers.
Industry RankSector Rank
Current Ratio 2.02
Quick Ratio 1.04
ENOV Yearly Current Assets VS Current LiabilitesENOV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

4

3. ENOV Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 16.61% over the past year.
  • Measured over the past years, ENOV shows a decrease in Earnings Per Share. The EPS has been decreasing by -4.57% on average per year.
  • The Revenue has been growing slightly by 6.66% in the past year.
  • Measured over the past years, ENOV shows a decrease in Revenue. The Revenue has been decreasing by -6.05% on average per year.
EPS 1Y (TTM)16.61%
EPS 3Y13.28%
EPS 5Y-4.57%
EPS Q2Q%-3.06%
Revenue 1Y (TTM)6.66%
Revenue growth 3Y12.88%
Revenue growth 5Y-6.05%
Sales Q2Q%2.64%

3.2 Future

  • Based on estimates for the next years, ENOV will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.35% on average per year.
  • The Revenue is expected to grow by 4.56% on average over the next years.
EPS Next Y9.27%
EPS Next 2Y10.94%
EPS Next 3Y11.35%
EPS Next 5YN/A
Revenue Next Year4.04%
Revenue Next 2Y4.8%
Revenue Next 3Y4.56%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ENOV Yearly Revenue VS EstimatesENOV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B 4B
ENOV Yearly EPS VS EstimatesENOV Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6

8

4. ENOV Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 6.97, the valuation of ENOV can be described as very cheap.
  • ENOV's Price/Earnings ratio is rather cheap when compared to the industry. ENOV is cheaper than 96.74% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 25.70. ENOV is valued rather cheaply when compared to this.
  • ENOV is valuated cheaply with a Price/Forward Earnings ratio of 6.38.
  • 98.37% of the companies in the same industry are more expensive than ENOV, based on the Price/Forward Earnings ratio.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 23.84, ENOV is valued rather cheaply.
Industry RankSector Rank
PE 6.97
Fwd PE 6.38
ENOV Price Earnings VS Forward Price EarningsENOV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ENOV is valued cheaply inside the industry as 94.02% of the companies are valued more expensively.
  • ENOV's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. ENOV is cheaper than 71.74% of the companies in the same industry.
Industry RankSector Rank
P/FCF 66.08
EV/EBITDA 8.3
ENOV Per share dataENOV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • ENOV's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.75
PEG (5Y)N/A
EPS Next 2Y10.94%
EPS Next 3Y11.35%

0

5. ENOV Dividend Analysis

5.1 Amount

  • ENOV does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

ENOV Fundamentals: All Metrics, Ratios and Statistics

ENOVIS CORP

NYSE:ENOV (3/13/2026, 8:22:59 PM)

After market: 22.99 0 (0%)

22.99

-0.4 (-1.71%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-26
Earnings (Next)05-06
Inst Owners117.76%
Inst Owner Change-0.07%
Ins Owners1.22%
Ins Owner Change9.21%
Market Cap1.32B
Revenue(TTM)2.25B
Net Income(TTM)-1.18B
Analysts84.44
Price Target46.36 (101.65%)
Short Float %15.5%
Short Ratio7.88
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.33%
Min EPS beat(2)13.32%
Max EPS beat(2)13.35%
EPS beat(4)4
Avg EPS beat(4)10.31%
Min EPS beat(4)6.8%
Max EPS beat(4)13.35%
EPS beat(8)8
Avg EPS beat(8)8.3%
EPS beat(12)12
Avg EPS beat(12)8.63%
EPS beat(16)16
Avg EPS beat(16)9.44%
Revenue beat(2)0
Avg Revenue beat(2)-1.7%
Min Revenue beat(2)-3.32%
Max Revenue beat(2)-0.09%
Revenue beat(4)0
Avg Revenue beat(4)-1.4%
Min Revenue beat(4)-3.32%
Max Revenue beat(4)-0.09%
Revenue beat(8)1
Avg Revenue beat(8)-1.24%
Revenue beat(12)4
Avg Revenue beat(12)-0.78%
Revenue beat(16)5
Avg Revenue beat(16)-1.09%
PT rev (1m)0%
PT rev (3m)-5.52%
EPS NQ rev (1m)5.69%
EPS NQ rev (3m)5.68%
EPS NY rev (1m)3.06%
EPS NY rev (3m)2.67%
Revenue NQ rev (1m)-1.31%
Revenue NQ rev (3m)-1.26%
Revenue NY rev (1m)-0.62%
Revenue NY rev (3m)-0.58%
Valuation
Industry RankSector Rank
PE 6.97
Fwd PE 6.38
P/S 0.59
P/FCF 66.08
P/OCF 6.06
P/B 0.88
P/tB N/A
EV/EBITDA 8.3
EPS(TTM)3.3
EY14.35%
EPS(NY)3.61
Fwd EY15.68%
FCF(TTM)0.35
FCFY1.51%
OCF(TTM)3.8
OCFY16.51%
SpS39.27
BVpS26.02
TBVpS-8.13
PEG (NY)0.75
PEG (5Y)N/A
Graham Number43.95
Profitability
Industry RankSector Rank
ROA -30.89%
ROE -79.51%
ROCE 0.58%
ROIC 0.46%
ROICexc 0.46%
ROICexgc 1.19%
OM 0.84%
PM (TTM) N/A
GM 58.16%
FCFM 0.89%
ROA(3y)-16.37%
ROA(5y)-9.72%
ROE(3y)-37.57%
ROE(5y)-22.31%
ROIC(3y)0.36%
ROIC(5y)N/A
ROICexc(3y)0.36%
ROICexc(5y)N/A
ROICexgc(3y)1.26%
ROICexgc(5y)N/A
ROCE(3y)0.45%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-36.37%
ROICexc growth 3YN/A
ROICexc growth 5Y-29.16%
OM growth 3YN/A
OM growth 5Y-34.45%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.43%
GM growth 5Y6.64%
F-Score4
Asset Turnover0.59
Health
Industry RankSector Rank
Debt/Equity 0.85
Debt/FCF 65.11
Debt/EBITDA 4.03
Cap/Depr 67.05%
Cap/Sales 8.78%
Interest Coverage 0.69
Cash Conversion 69.38%
Profit Quality N/A
Current Ratio 2.02
Quick Ratio 1.04
Altman-Z 0.6
F-Score4
WACC8.14%
ROIC/WACC0.06
Cap/Depr(3y)62.27%
Cap/Depr(5y)54.89%
Cap/Sales(3y)8.17%
Cap/Sales(5y)7.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.61%
EPS 3Y13.28%
EPS 5Y-4.57%
EPS Q2Q%-3.06%
EPS Next Y9.27%
EPS Next 2Y10.94%
EPS Next 3Y11.35%
EPS Next 5YN/A
Revenue 1Y (TTM)6.66%
Revenue growth 3Y12.88%
Revenue growth 5Y-6.05%
Sales Q2Q%2.64%
Revenue Next Year4.04%
Revenue Next 2Y4.8%
Revenue Next 3Y4.56%
Revenue Next 5YN/A
EBIT growth 1Y53.77%
EBIT growth 3YN/A
EBIT growth 5Y-38.41%
EBIT Next Year53.87%
EBIT Next 3Y21.57%
EBIT Next 5YN/A
FCF growth 1Y129.63%
FCF growth 3YN/A
FCF growth 5Y-36.11%
OCF growth 1Y91.44%
OCF growth 3YN/A
OCF growth 5Y-6.37%

ENOVIS CORP / ENOV Fundamental Analysis FAQ

What is the ChartMill fundamental rating of ENOVIS CORP (ENOV) stock?

ChartMill assigns a fundamental rating of 4 / 10 to ENOV.


What is the valuation status of ENOVIS CORP (ENOV) stock?

ChartMill assigns a valuation rating of 8 / 10 to ENOVIS CORP (ENOV). This can be considered as Undervalued.


Can you provide the profitability details for ENOVIS CORP?

ENOVIS CORP (ENOV) has a profitability rating of 4 / 10.


What is the earnings growth outlook for ENOVIS CORP?

The Earnings per Share (EPS) of ENOVIS CORP (ENOV) is expected to grow by 9.27% in the next year.